Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | BMY | MRNA | AMGN | GILD |
| Company | Blueprint Medicines Corp | Bristol-Myers Squibb Company | Moderna Inc | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 105.99 | 43.98 | 122.86 | 301.75 | 65.43 |
| High | 106.33 | 44.20 | 123.50 | 302.62 | 65.84 |
| Low | 103.31 | 43.98 | 121.30 | 300.01 | 65.16 |
| Last | 105.50 | 44.04 | 120.51 | 301.03 | 65.41 |
| Change | -0.75 | +0.14 | -1.62 | +1.55 | -0.13 |
| % Change | -0.71% | +0.32% | -1.33% | +0.52% | -0.20% |
| Volume | 36,331 | 709,793 | 387,291 | 236,388 | 374,245 |
| 20-Day Average Volume | 709,277 | 13,868,965 | 3,231,439 | 2,713,415 | 7,258,667 |
| Previous Close | 106.25 | 43.90 | 122.13 | 299.48 | 65.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 93.49 | 46.73 | 109.86 | 275.38 | 66.47 |
| 20-Day Raw Stochastic | 80.71% | 9.27% | 76.72% | 67.28% | 22.28% |
| 20-Day Relative Strength | 65.51% | 30.13% | 64.13% | 63.89% | 34.71% |
| Weighted Alpha | +111.71 | -36.04 | +9.00 | +29.35 | -20.00 |
| Today's Opinion | 100% Buy | 100% Sell | 100% Buy | 40% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 100% Sell | 100% Buy | 24% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 32% Sell | 56% Buy | 24% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +15.83% since 04/30/24 | +0.30% since 04/30/24 | +10.54% since 04/30/24 | +10.37% since 04/30/24 | +0.52% since 04/30/24 |
| Low | 90.85 on 05/01/24 | 43.33 on 05/02/24 | 109.00 on 05/01/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 |
| High | 110.93 on 05/03/24 | 44.62 on 05/06/24 | 128.81 on 05/02/24 | 322.60 on 05/03/24 | 65.89 on 05/01/24 |
| 1-Month | |||||
| %Chg | +15.44% since 04/05/24 | -14.13% since 04/05/24 | +18.53% since 04/05/24 | +12.00% since 04/05/24 | -5.81% since 04/05/24 |
| Low | 84.33 on 04/15/24 | 43.33 on 05/02/24 | 99.30 on 04/22/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 110.93 on 05/03/24 | 51.68 on 04/09/24 | 128.81 on 05/02/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 |
| 3-Month | |||||
| %Chg | +42.59% since 02/07/24 | -9.40% since 02/07/24 | +22.80% since 02/07/24 | +2.19% since 02/07/24 | -11.93% since 02/07/24 |
| Low | 72.24 on 02/14/24 | 43.33 on 05/02/24 | 84.06 on 02/13/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 110.93 on 05/03/24 | 55.03 on 03/13/24 | 128.81 on 05/02/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 |
| 6-Month | |||||
| %Chg | +74.53% since 11/07/23 | -15.72% since 11/07/23 | +65.54% since 11/07/23 | +11.52% since 11/07/23 | -18.69% since 11/07/23 |
| Low | 56.74 on 11/13/23 | 43.33 on 05/02/24 | 67.62 on 11/13/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 |
| High | 110.93 on 05/03/24 | 55.03 on 03/13/24 | 128.81 on 05/02/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,502,500 | 88,989,688 | 46,805,100 | 160,633,888 | 81,602,352 |
| Shares Outstanding, K | 61,200 | 2,027,100 | 383,240 | 536,376 | 1,245,077 |
| Annual Sales | 249,380,000 | 45,006,000,000 | 6,848,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -506,980,000 | 8,025,000,000 | -4,714,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 96,120,000 | 11,865,000,000 | 167,000,000 | 7,447,000,000 | 6,686,000,000 |
| Last Quarter Net Income | 89,140,000 | -11,911,000,000 | -1,175,000,000 | -113,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.65 | 0.45 | 1.57 | 0.60 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.32 on 05/02/24 | -4.40 on 04/25/24 | -3.07 on 05/02/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | N/A | 05/16/24 | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.90 | 0.00 | 16.71 | 16.07 |